Header Logo

Connection

Peter Friedmann to Prisoners

Back to Details
This is a "connection" page, showing publications Peter Friedmann has written about Prisoners.
Peter Friedmann
Connection Strength
5.952
Prisoners
  1. Michener PS, Bianchet E, Fox S, Evans EA, Friedmann PD. "Expected to happen": perspectives on post-release overdose from recently incarcerated people with opioid use disorder. Harm Reduct J. 2024 07 22; 21(1):138.
    View in: PubMed
    Score: 0.792
  2. Evans EA, Pivovarova E, Senthilkumar R, Rottapel RE, Stopka TJ, Santelices C, Ferguson WJ, Friedmann PD. Diversion of medications to treat opioid use disorder: Qualitative findings from formerly incarcerated adults in Massachusetts. Int J Drug Policy. 2023 Dec; 122:104252.
    View in: PubMed
    Score: 0.756
  3. Friedmann PD, Wilson D, Hoskinson R, Poshkus M, Clarke JG. Initiation of extended release naltrexone (XR-NTX) for opioid use disorder prior to release from prison. J Subst Abuse Treat. 2018 02; 85:45-48.
    View in: PubMed
    Score: 0.479
  4. Welsh WN, Knudsen HK, Knight K, Ducharme L, Pankow J, Urbine T, Lindsey A, Abdel-Salam S, Wood J, Monico L, Link N, Albizu-Garcia C, Friedmann PD. Effects of an Organizational Linkage Intervention on Inter-Organizational Service Coordination Between Probation/Parole Agencies and Community Treatment Providers. Adm Policy Ment Health. 2016 Jan; 43(1):105-21.
    View in: PubMed
    Score: 0.438
  5. Friedmann PD, Wilson D, Knudsen HK, Ducharme LJ, Welsh WN, Frisman L, Knight K, Lin HJ, James A, Albizu-Garcia CE, Pankow J, Hall EA, Urbine TF, Abdel-Salam S, Duvall JL, Vocci FJ. Effect of an organizational linkage intervention on staff perceptions of medication-assisted treatment and referral intentions in community corrections. J Subst Abuse Treat. 2015 Mar; 50:50-8.
    View in: PubMed
    Score: 0.402
  6. Frank JW, Andrews CM, Green TC, Samuels AM, Trinh TT, Friedmann PD. Emergency department utilization among recently released prisoners: a retrospective cohort study. BMC Emerg Med. 2013 Nov 05; 13:16.
    View in: PubMed
    Score: 0.377
  7. Green TC, Johnson J, Harrington M, Pouget ER, Rhodes AG, Taxman FS, O'Connell DJ, Martin SS, Prendergast M, Friedmann PD. Parole officer-parolee relationships and HIV risk behaviors during community supervision. AIDS Behav. 2013 Oct; 17(8):2667-75.
    View in: PubMed
    Score: 0.374
  8. Green TC, Pouget ER, Harrington M, Taxman FS, Rhodes AG, O'Connell D, Martin SS, Prendergast M, Friedmann PD. Limiting options: sex ratios, incarceration rates, and sexual risk behavior among people on probation and parole. Sex Transm Dis. 2012 Jun; 39(6):424-30.
    View in: PubMed
    Score: 0.341
  9. Friedmann PD, Green TC, Taxman FS, Harrington M, Rhodes AG, Katz E, O'Connell D, Martin SS, Frisman LK, Litt M, Burdon W, Clarke JG, Fletcher BW. Collaborative behavioral management among parolees: drug use, crime and re-arrest in the Step'n Out randomized trial. Addiction. 2012 Jun; 107(6):1099-108.
    View in: PubMed
    Score: 0.335
  10. Flanagan Balawajder E, Ducharme L, Taylor BG, Lamuda PA, Kolak M, Friedmann PD, Pollack HA, Schneider JA. Barriers to Universal Availability of Medications for Opioid Use Disorder in US Jails. JAMA Netw Open. 2025 Apr 01; 8(4):e255340.
    View in: PubMed
    Score: 0.208
  11. Christopher PP, Stein MD, Johnson JE, Rich JD, Friedmann PD, Clarke J, Lidz CW. Exploitation of Prisoners in Clinical Research: Perceptions of Study Participants. IRB. 2016 Jan-Feb; 38(1):7-12.
    View in: PubMed
    Score: 0.109
  12. Lantini R, van den Berg JJ, Roberts MB, Bock BC, Stein LA, Parker DR, Friedmann PD, Clarke JG. Characteristics of smoking used cigarettes among an incarcerated population. Psychol Addict Behav. 2015 Mar; 29(1):254-8.
    View in: PubMed
    Score: 0.100
  13. van den Berg JJ, Bock B, Roberts MB, Stein LA, Friedmann PD, Martin SA, Clarke JG. Cigarette smoking as an expression of independence and freedom among inmates in a tobacco-free prison in the United States. Nicotine Tob Res. 2014 Feb; 16(2):238-42.
    View in: PubMed
    Score: 0.094
  14. Zaller N, McKenzie M, Friedmann PD, Green TC, McGowan S, Rich JD. Initiation of buprenorphine during incarceration and retention in treatment upon release. J Subst Abuse Treat. 2013 Aug; 45(2):222-6.
    View in: PubMed
    Score: 0.090
  15. Calcaterra S, Blatchford P, Friedmann PD, Binswanger IA. Psychostimulant-related deaths among former inmates. J Addict Med. 2012 Jun; 6(2):97-105.
    View in: PubMed
    Score: 0.085
  16. McKenzie M, Zaller N, Dickman SL, Green TC, Parihk A, Friedmann PD, Rich JD. A randomized trial of methadone initiation prior to release from incarceration. Subst Abus. 2012; 33(1):19-29.
    View in: PubMed
    Score: 0.083
  17. Coviello DM, Cornish JW, Lynch KG, Boney TY, Clark CA, Lee JD, Friedmann PD, Nunes EV, Kinlock TW, Gordon MS, Schwartz RP, Nuwayser ES, O'Brien CP. A multisite pilot study of extended-release injectable naltrexone treatment for previously opioid-dependent parolees and probationers. Subst Abus. 2012; 33(1):48-59.
    View in: PubMed
    Score: 0.083
  18. Clarke JG, Martin RA, Stein L, Lopes CE, Mello J, Friedmann P, Bock B. Working Inside for Smoking Elimination (Project W.I.S.E.) study design and rationale to prevent return to smoking after release from a smoke free prison. BMC Public Health. 2011 Oct 05; 11:767.
    View in: PubMed
    Score: 0.082
  19. Johnson JE, Friedmann PD, Green TC, Harrington M, Taxman FS. Gender and treatment response in substance use treatment-mandated parolees. J Subst Abuse Treat. 2011 Apr; 40(3):313-21.
    View in: PubMed
    Score: 0.078
  20. Stein MD, Anderson BJ, Caviness CM, Rosengard C, Kiene S, Friedmann P, Clarke JG. Relationship of alcohol use and sexual risk taking among hazardously drinking incarcerated women: an event-level analysis. J Stud Alcohol Drugs. 2009 Jul; 70(4):508-15.
    View in: PubMed
    Score: 0.070
  21. Caviness CM, Hatgis C, Anderson BJ, Rosengard C, Kiene SM, Friedmann PD, Stein MD. Three brief alcohol screens for detecting hazardous drinking in incarcerated women. J Stud Alcohol Drugs. 2009 Jan; 70(1):50-4.
    View in: PubMed
    Score: 0.067
  22. Rhodes AG, Taxman FS, Friedmann PD, Cropsey KL. HCV in incarcerated populations: an analysis of gender and criminality on risk. J Psychoactive Drugs. 2008 Dec; 40(4):493-501.
    View in: PubMed
    Score: 0.067
  23. Zlotnick C, Clarke JG, Friedmann PD, Roberts MB, Sacks S, Melnick G. Gender differences in comorbid disorders among offenders in prison substance abuse treatment programs. Behav Sci Law. 2008; 26(4):403-12.
    View in: PubMed
    Score: 0.063
  24. Hebert MR, Clarke JG, Caviness CM, Ray MK, Friedmann PD, Stein MD. Feasibility of gaining access to women in jail for health interventions. Women Health. 2008; 47(3):79-93.
    View in: PubMed
    Score: 0.063
  25. Friedmann PD, Alexander JA, Yey Y, Nahra T, Soliman S, Pollack HA. Duration of nonmethadone outpatient treatment: results from a national survey. Subst Abus. 2006 Sep; 27(3):47-53.
    View in: PubMed
    Score: 0.057
  26. Stopka TJ, Rottapel R, Friedmann PD, Pivovarova E, Evans EA. Perceptions of extended-release buprenorphine among people who received medication for opioid use disorder in jail: a qualitative study. Addict Sci Clin Pract. 2024 Sep 12; 19(1):68.
    View in: PubMed
    Score: 0.050
  27. Flanagan Balawajder E, Ducharme L, Taylor BG, Lamuda PA, Kolak M, Friedmann PD, Pollack HA, Schneider JA. Factors Associated With the Availability of Medications for Opioid Use Disorder in US Jails. JAMA Netw Open. 2024 09 03; 7(9):e2434704.
    View in: PubMed
    Score: 0.050
  28. Bovell-Ammon BJ, Yan S, Dunn D, Evans EA, Friedmann PD, Walley AY, LaRochelle MR. Receipt of medications for opioid use disorder before and after incarceration in Massachusetts State prisons, 2014-2019. Drug Alcohol Depend. 2024 Sep 01; 262:111392.
    View in: PubMed
    Score: 0.049
  29. Stein LAR, Bassett SS, Welsh WN, Clair-Michaud M, Abdel-Salam S, Monico L, Gallagher C, Murgo C, Yang Y, Friedmann PD, Clarke JG. Implementation Strategy Fidelity and Organizational Outcomes in a Randomized Trial: Implications for Reentry from Corrections to?Community Treatment. Subst Use Misuse. 2023; 58(3):320-330.
    View in: PubMed
    Score: 0.045
  30. Lubelczyk RA, Friedmann PD, Lemon SC, Stein MD, Gerstein DR. HIV prevention services in correctional drug treatment programs: do they change risk behaviors? AIDS Educ Prev. 2002 Apr; 14(2):117-25.
    View in: PubMed
    Score: 0.042
  31. Sacks S, Cleland CM, Melnick G, Flynn PM, Knight K, Friedmann PD, Prendergast ML, Coen C. Violent offenses associated with co-occurring substance use and mental health problems: evidence from CJDATS. Behav Sci Law. 2009 Jan-Feb; 27(1):51-69.
    View in: PubMed
    Score: 0.017
  32. Choopanya K, Vanichseni S, Des Jarlais DC, Plangsringarm K, Sonchai W, Carballo M, Friedmann P, Friedman SR. Risk factors and HIV seropositivity among injecting drug users in Bangkok. AIDS. 1991 Dec; 5(12):1509-13.
    View in: PubMed
    Score: 0.005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.